Recommended Reading / Paid-only The GLP-1 Patent Split: A Contrast of How Major Markets Deal With The Loss of Exclusivity [Analysis] Newsletter Edition #377 [The Files In-Depth] Subscribe Now! Readers, In today's edition, my colleague Anne Jomard sinks her teeth into examining the moat of intellectual property protection By Priti Patnaik / 27 Aug 2026
WIPO / Paid-only Using TRIPS Flexibilities: Easier Said Than Done? [Update from WIPO SCP] Newsletter Edition #237 [The Files In-Depth] By Priti Patnaik / 8 Nov 2024
COVID-19 / Paid-only Reforms to the International Health Regulations Must Advance Human Rights [GUEST ESSAY]; TRIPS Extension Decision for COVID-19 Tests & Treatments Junked at WTO Ministerial Newsletter Edition #70 [Treaty Talks] By Priti Patnaik / 8 Mar 2024
Pricing Johnson & Johnson’s Patenting & Pricing Strategy for TB Medicine Bedaquiline: A Cautionary Tale for New TB Medicines [GUEST ESSAY] Newsletter Edition #200 [The Curated Primer] By Priti Patnaik / 6 Oct 2023